Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model
Chiara Liverani,
Federico La Manna,
Arwin Groenewoud,
Laura Mercatali,
Gabri Van Der Pluijm,
Federica Pieri,
Davide Cavaliere,
Alessandro De Vita,
Chiara Spadazzi,
Giacomo Miserocchi,
Alberto Bongiovanni,
Federica Recine,
Nada Riva,
Dino Amadori,
Ennio Tasciotti,
Ewa Snaar-Jagalska,
Toni Ibrahim
Affiliations
Chiara Liverani
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Federico La Manna
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Arwin Groenewoud
Department of Molecular Cell Biology, Institute of Biology, Leiden University, Sylviusweg 72, Leiden 2333BE, The Netherlands
Laura Mercatali
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Gabri Van Der Pluijm
Leiden University Medical Center, Department of Urology, J-3-100, Albinusdreef 2, Leiden 2333ZA, The Netherlands
Federica Pieri
Pathology Unit, Morgagni-Pierantoni Hospital, Forlì 47121, Italy
Davide Cavaliere
Unit of Surgery and Advanced Oncologic Therapies, Morgagni-Pierantoni Hospital, Forlì 47121, Italy
Alessandro De Vita
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Chiara Spadazzi
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Giacomo Miserocchi
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Alberto Bongiovanni
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Federica Recine
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Nada Riva
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Dino Amadori
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Ennio Tasciotti
Department of Regenerative Medicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, TX 77030, USA
Ewa Snaar-Jagalska
Department of Molecular Cell Biology, Institute of Biology, Leiden University, Sylviusweg 72, Leiden 2333BE, The Netherlands
Toni Ibrahim
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola 47014, Italy
Patient-derived specimens are an invaluable resource to investigate tumor biology. However, in vivo studies on primary cultures are often limited by the small amount of material available, while conventional in vitro systems might alter the features and behavior that characterize cancer cells. We present our data obtained on primary dedifferentiated liposarcoma cells cultured in a 3D scaffold-based system and injected into a zebrafish model. Primary cells were characterized in vitro for their morphological features, sensitivity to drugs and biomarker expression, and in vivo for their engraftment and invasiveness abilities. The 3D culture showed a higher enrichment in cancer cells than the standard monolayer culture and a better preservation of liposarcoma-associated markers. We also successfully grafted primary cells into zebrafish, showing their local migratory and invasive abilities. Our work provides proof of concept of the ability of 3D cultures to maintain the original phenotype of ex vivo cells, and highlights the potential of the zebrafish model to provide a versatile in vivo system for studies with limited biological material. Such models could be used in translational research studies for biomolecular analyses, drug screenings and tumor aggressiveness assays.